GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

The cost, the shortages, and even the side effects have led to older people who start Ozempic, Wegovy, and similar drugs to ...

America’s least healthy states also have a few things in common, according to a new report. Here's where your state ranks.

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Healthcare investing offers defensive characteristics during market turbulence, yet regulatory uncertainty and political risk ...

YEAR AFTER YEAR, Mary Bucklew strategized with a nurse practitioner about losing weight. "We tried exercise," like walking 35 ...

A Westminster man was arrested Jan. 2 following a traffic stop in Greenwood that led to multiple drug-related charges and a DUI, according to the South Carolina Highway Patrol.

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...

The index's mix of banking, mining, defence and pharma companies means London is home to a healthy blend of major players in ...

Alumis, a clinical-stage biopharmaceutical company, has announced two phase 3 trials of its TYK2 inhibitor envudeucitinib met their co-primary endpoints in adults with moderate to severe plaque ...

President Donald Trump’s rejection of the postwar global system has sparked concerns about the future of international ...